Möchten Sie immer auf dem neuesten Stand bleiben?

New analyses from the Phase 3 Vivacity-MG3 study support the impact of nipocalimab in anti-AChR+a, anti-MuSK+b adult patients with generalised myasthenia gravis (gMG) including those early in their...

Austin, United States, June 26, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Biodefense Market size was valued at USD 17.70 Billion in 2025 and is projected to reach USD 29.17 Billion by...

NYSE: KULR today published a letter from the Company's Chairman and Chief Executive Officer, Michael Mo.

OpenAI & Broadcom unveil Jalapeño–OpenAI’s first Intelligence Processor: an accelerator architected around OpenAI’s vision for the future of LLM inference.

GAAP quarterly revenue of $193.4 million; record core revenue of $191.3 million, up 92% from a year agoAnnounced a multi-year deal with OpenAI for 750MW valued at more than $20 billionLaunched...

First-wave participation in OpenAI TAC deepens Presidio’s ability to help enterprises identify, validate and prioritize cyber risk at AI speed.

On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer ...

Novel immune reprogramming oral macrocyclic peptides designed for precise modulation of complex biological networks involved in inflammatory, autoimmune and fibro-inflammatory diseases Company...

LAWRENCEVILLE, N.J., June 22, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that Stacy...

COLUMBIA, Md., June 22, 2026 (GLOBE NEWSWIRE) -- Tenable® Holdings, Inc. (NASDAQ: TENB), the exposure management company, today announced it is working with OpenAI as part of the OpenAI Daybreak...